Status:
UNKNOWN
The National Oncologic PET Registry
Lead Sponsor:
American College of Radiology Imaging Network
Collaborating Sponsors:
World Molecular Imaging Society (formerly Academy of Molecular Imaging)
Conditions:
Cancer
Eligibility:
All Genders
Brief Summary
The Centers for Medicare \& Medicaid Services (CMS), as the Federal agency that administers the Medicare program, only pays for positron emission tomography (PET) scans in patients with cancer for cer...
Detailed Description
The National Oncologic PET Registry (NOPR) was developed in response to the Centers for Medicare \& Medicaid Services (CMS) proposal to expand coverage for positron emission tomography with F-18 fluor...
Eligibility Criteria
Inclusion
- All Medicare beneficiaries who are referred for NaF-18 PET to identify bone metastasis are eligible to be included in the NOPR.
Exclusion
- NaF-18 PET for other (non-oncologic) indications.
- NaF-18 PET performed as part of a clinical trial approved by CMS.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
333000 Patients enrolled
Trial Details
Trial ID
NCT00868582
Start Date
May 1 2006
End Date
June 1 2021
Last Update
August 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American College of Radiology Imaging Network
Philadelphia, Pennsylvania, United States, 19103